Clinical trials: Laryngomalacia

Laryngomalacia, Gastro Esophageal Reflux

Initiation of Acid Suppression Therapy Prospective Outcomes for Laryngomalacia

• Terminated
• Age: 0 to 6 months
• Phase 1/2
• Results posted

Laryngomalacia (LM) is the most common cause of stridor in infants. Symptoms of gastroesophageal reflux (GER) are often seen in the setting of LM; therefore, acid suppression therapy (AST) has been empirically used in the…

Trial name

NCT04614974

Testing

Famotidine, Speech Language Therapy

Where

United States

Volunteers

65 people

Sponsor

Reema Padia